Clinical Trial Update: CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE)

View source ↗

Summary

The CASTLE study on cardiovascular risk assessment in systemic lupus erythematosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Systemic Lupus Erythematosus | Status: COMPLETED